Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Paxton

Showing results (191-200 of 213) with videos related to

Pageof 22
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|September 28, 2018
SNP rs688 within the low-density lipoprotein receptor (LDL-R) gene associates with HCV susceptibilityGaby S Steba, Sylvie M Koekkoek, Michael W T Tanck, et al.
AIDS (London, England)|May 19, 2015
The impact of adherence to preexposure prophylaxis on the risk of HIV infection among people who inject drugsMichael Martin, Suphak Vanichseni, Pravan Suntharasamai, et al.
Malaria Journal|August 16, 2017
Artemisinin combination therapy mass drug administration in a setting of low malaria endemicity: programmatic coverage and adherence during an observational study in ZanzibarAbdullah S Ali, Narjis G Thawer, Bakar Khatib, et al.
AIDS (London, England)|November 5, 1999
Relative risks and population attributable fraction of incident HIV associated with symptoms of sexually transmitted diseases and treatable symptomatic sexually transmitted diseases in Rakai District, Uganda. Rakai Project TeamR H Gray, M J Wawer, N K Sewankambo, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 8, 2013
Randomized trial of clinical safety of daily oral tenofovir disoproxil fumarate among HIV-uninfected men who have sex with men in the United StatesLisa A Grohskopf, Kata L Chillag, Roman Gvetadze, et al.
Lancet (London, England)|February 24, 1999
Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial. Rakai Project Study GroupM J Wawer, N K Sewankambo, D Serwadda, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 16, 2014
Renal function of participants in the Bangkok tenofovir study--Thailand, 2005-2012Michael Martin, Suphak Vanichseni, Pravan Suntharasamai, et al.
Plos One|December 31, 2015
Assessment of Oral Fluid HIV Test Performance in an HIV Pre-Exposure Prophylaxis Trial in Bangkok, ThailandPravan Suntharasamai, Michael Martin, Kachit Choopanya, et al.
The Lancet. HIV|November 22, 2016
Factors associated with the uptake of and adherence to HIV pre-exposure prophylaxis in people who have injected drugs: an observational, open-label extension of the Bangkok Tenofovir StudyMichael Martin, Suphak Vanichseni, Pravan Suntharasamai, et al.
Nature Medicine|November 1, 1996
The role of a mutant CCR5 allele in HIV-1 transmission and disease progressionY Huang, W A Paxton, S M Wolinsky, et al.
Pageof 22

Showing results (191-200 of 213) with videos related to

Sort By:
Pageof 22
Liver International : Official Journal of the International Association for the Study of the Liver|September 28, 2018
SNP rs688 within the low-density lipoprotein receptor (LDL-R) gene associates with HCV susceptibilityGaby S Steba, Sylvie M Koekkoek, Michael W T Tanck, et al.
AIDS (London, England)|May 19, 2015
The impact of adherence to preexposure prophylaxis on the risk of HIV infection among people who inject drugsMichael Martin, Suphak Vanichseni, Pravan Suntharasamai, et al.
Malaria Journal|August 16, 2017
Artemisinin combination therapy mass drug administration in a setting of low malaria endemicity: programmatic coverage and adherence during an observational study in ZanzibarAbdullah S Ali, Narjis G Thawer, Bakar Khatib, et al.
AIDS (London, England)|November 5, 1999
Relative risks and population attributable fraction of incident HIV associated with symptoms of sexually transmitted diseases and treatable symptomatic sexually transmitted diseases in Rakai District, Uganda. Rakai Project TeamR H Gray, M J Wawer, N K Sewankambo, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 8, 2013
Randomized trial of clinical safety of daily oral tenofovir disoproxil fumarate among HIV-uninfected men who have sex with men in the United StatesLisa A Grohskopf, Kata L Chillag, Roman Gvetadze, et al.
Lancet (London, England)|February 24, 1999
Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial. Rakai Project Study GroupM J Wawer, N K Sewankambo, D Serwadda, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 16, 2014
Renal function of participants in the Bangkok tenofovir study--Thailand, 2005-2012Michael Martin, Suphak Vanichseni, Pravan Suntharasamai, et al.
Plos One|December 31, 2015
Assessment of Oral Fluid HIV Test Performance in an HIV Pre-Exposure Prophylaxis Trial in Bangkok, ThailandPravan Suntharasamai, Michael Martin, Kachit Choopanya, et al.
The Lancet. HIV|November 22, 2016
Factors associated with the uptake of and adherence to HIV pre-exposure prophylaxis in people who have injected drugs: an observational, open-label extension of the Bangkok Tenofovir StudyMichael Martin, Suphak Vanichseni, Pravan Suntharasamai, et al.
Nature Medicine|November 1, 1996
The role of a mutant CCR5 allele in HIV-1 transmission and disease progressionY Huang, W A Paxton, S M Wolinsky, et al.
Pageof 22